SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Felson DT. Obesity and vocational and avocational overload of the joint as risk factors for osteoarthritis. J Rheumatol Suppl 2004; 70: 25.
  • 2
    Flugsrud GB, Nordsletten L, Espehaug B et al. The impact of body mass index on later total hip arthroplasty for primary osteoarthritis: a cohort study in 1.2 million persons. Arthritis Rheum 2006; 54: 802807.
  • 3
    Flugsrud GB, Nordsletten L, Espehaug B, Havelin LI, Meyer HE. Risk factors for total hip replacement due to primary osteoarthritis: a cohort study in 50,034 persons. Arthritis Rheum 2002; 46: 675682.
  • 4
    Karlson EW, Mandl LA, Aweh GN et al. Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors. Am J Med 2003; 114: 9398.
  • 5
    Lau EC, Cooper C, Lam D et al. Factors associated with osteoarthritis of the hip and knee in Hong Kong Chinese: obesity, joint injury, and occupational activities. Am J Epidemiol 2000; 152: 855862.
  • 6
    Lievense AM, Bierma-Zeinstra SM, Verhagen AP et al. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology (Oxford) 2002; 41: 11551162.
  • 7
    Radin EL. Who gets osteoarthritis and why? J Rheumatol Suppl 2004; 70: 1015.
  • 8
    Cimmino MA, Sarzi-Puttini P, Scarpa R et al. Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study. Semin Arthritis Rheum 2005; 35: 1723.
  • 9
    Garnero P, Mazieres B, Gueguen A et al. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol 2005; 32: 697703.
  • 10
    Jacobsen S, Sonne-Holm S. Increased body mass index is a predisposition for treatment by total hip replacement. Int Orthop 2005; 29: 229234.
  • 11
    Marks R. Obesity profiles with knee osteoarthritis: correlation with pain, disability, disease progression. Obesity (Silver Spring) 2007; 15: 18671874.
  • 12
    Penninx BW, Abbas H, Ambrosius W et al. Inflammatory markers and physical function among older adults with knee osteoarthritis. J Rheumatol 2004; 31: 20272031.
  • 13
    Spector TD, Hart DJ, Nandra D et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997; 40: 723727.
  • 14
    Sturmer T, Brenner H, Koenig W, Gunther KP. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 2004; 63: 200205.
  • 15
    Wolfe F. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol 1997; 24: 14861488.
  • 16
    Lubbeke A, Katz JN, Perneger TV, Hoffmeyer P. Primary and revision hip arthroplasty: 5-year outcomes and influence of age and comorbidity. J Rheumatol 2007; 34: 394400.
  • 17
    WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. World Health Organization: Geneva, 2000.
  • 18
    Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 1969; 51: 737755.
  • 19
    Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 18331840.
  • 20
    Whitehouse SL, Lingard EA, Katz JN, Learmonth ID. Development and testing of a reduced WOMAC function scale. J Bone Joint Surg Br 2003; 85: 706711.
  • 21
    Gunther KP, Sun Y. Reliability of radiographic assessment in hip and knee osteoarthritis. Osteoarthritis Cartilage 1999; 7: 239246.
  • 22
    Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494502.
  • 23
    Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage 2007; 15 Suppl A: A1A56.
  • 24
    Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220233.
  • 25
    Stickles B, Phillips L, Brox WT, Owens B, Lanzer WL. Defining the relationship between obesity and total joint arthroplasty. Obes Res 2001; 9: 219223.
  • 26
    Lubbeke A, Stern R, Garavaglia G, Zurcher L, Hoffmeyer P. Differences in outcomes of obese women and men undergoing primary total hip arthroplasty. Arthritis Rheum 2007; 57: 32734.
  • 27
    Lane NE, Nevitt MC, Hochberg MC, Hung YY, Palermo L. Progression of radiographic hip osteoarthritis over eight years in a community sample of elderly white women. Arthritis Rheum 2004; 50: 14771486.
  • 28
    Jacobsen S, Sonne-Holm S, Soballe K, Gebuhr P, Lund B. Radiographic case definitions and prevalence of osteoarthrosis of the hip: a survey of 4151 subjects in the Osteoarthritis Substudy of the Copenhagen City Heart Study. Acta Orthop Scand 2004; 75: 713720.
  • 29
    Hulens M, Vansant G, Lysens R et al. Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach. Int J Obes Relat Metab Disord 2001; 25: 676681.
  • 30
    Haywood L, McWilliams DF, Pearson CI et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003; 48: 21732177.
  • 31
    Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001; 44: 12371247.
  • 32
    Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997; 24: 365371.
  • 33
    Cesari M, Penninx BW, Pahor M et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004; 59: 242248.
  • 34
    Schrager MA, Metter EJ, Simonsick E et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 2007; 102: 919925.
  • 35
    Stenholm S, Rantanen T, Heliovaara M, Koskinen S. The Mediating Role of C-reactive protein and handgrip strength between obesity and walking limitation. J Am Geriatr Soc 2008; 56: 558560.
  • 36
    Christensen R, Astrup A, Bliddal H. Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial. Osteoarthritis Cartilage 2005; 13: 2027.
  • 37
    Toda Y, Toda T, Takemura S et al. Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol 1998; 25: 21812186.
  • 38
    Eaton CB. Obesity as a risk factor for osteoarthritis: mechanical versus metabolic. Med Health R I 2004; 87: 201204.
  • 39
    Griffin TM, Guilak F. The role of mechanical loading in the onset and progression of osteoarthritis. Exerc Sport Sci Rev 2005; 33: 195200.
  • 40
    Dawson J, Fitzpatrick R, Murray D, Carr A. The problem of ‘noise’ in monitoring patient-based outcomes: generic, disease-specific and site-specific instruments for total hip replacement. J Health Serv Res Policy 1996; 1: 224231.
  • 41
    McGee MA, Howie DW, Ryan P, Moss JR, Holubowycz OT. Comparison of patient and doctor responses to a total hip arthroplasty clinical evaluation questionnaire. J Bone Joint Surg Am 2002; 84-A: 17451752.
  • 42
    Creamer P, Hochberg MC. The relationship between psychosocial variables and pain reporting in osteoarthritis of the knee. Arthritis Care Res 1998; 11: 6065.